We have produced monoclonal antibodies (mAbs) against human Toll-like receptors (TLRs). These mAbs recognize the natural conformation of the extracellular domain leucine-rich repeats and, thereby, are suitable for immunoprecipitation, flow cytometric analysis and immunostaining. Using these mAbs, we determined the distribution of TLRs in a variety of human cell populations. Human TLRs that recognize bacterial components, particularly TLR-1, TLR-2, TLR-4 and TLR-6, reside on the cell surface and are expressed in myeloid and monocyte-derived dendritic cells (DCs) but not in plasmacytoid DCs (pDCs). Human TLR-3 resides in putative endosomes in myeloid DCs. Thus, the human myeloid DC subset harbors a unique and distinctive TLR repertoire. These mAbs will be useful to test the localization and distribution of human TLRs in a variety of cells and organs. Functional studies of human TLRs will also be feasible since certain of them are function-blocking mAbs.
Janeway Jr CA , Medzhitov R.Innate immune recognition. Annu Rev Immunol2002; 20: 197—216.
2.
Seya T., Akazawa T., Uehori J., Matsumoto M., Azuma I., Toyoshima K.Role of Toll-like receptors and their adapters in adjuvant immunotherapy for cancer. Anticancer Res2003; 23: 4369—4376.
3.
Takeda K., Kaisho T., Akira S.Toll-like receptors. Annu Rev Immunol2003 ; 21: 335—376.
4.
Honda K., Yanai H., Negishi H. et al. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature2005; 434: 772—777.
5.
Takaoka A., Yanai H., Kondo S. et al. Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors. Nature2005; 434: 243—249.
6.
Kawai T., Sato S., Ishii KJ et al. Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Nat Immunol2004; 5: 1061—1068.
7.
Seya T., Oshiumi H., Akazawa T., Matsumoto M.TICAM-1 and TICAM-2: Toll-like receptor adapters that participate in induction of type 1 interferons. Int J Biochem Cell Biol2005; 37: 524—529.
8.
Matsumoto M. , Kikkawa S., Kohase M., Miyake K., Seya T.Establishment of a monoclonal antibody against human Toll-like receptor 3 that blocks double-stranded RNA-mediated signaling . Biochem Biophys Res Commun2002; 293: 1364—1369.
9.
Uehori J., Matsumoto M., Tsuji S. et al. Simultaneous blocking of human Toll-like receptor 2 and 4 suppresses myeloid dendritic cell activation induced by Mycobacterium bovis bacillus Calmette-Guérin (BCG)-peptidoglycan (PGN). Infect Immun2003; 71: 4238—4249.
10.
Matsumoto M. , Funami K., Tanabe M. et al. Subcellular localization of human Toll-like receptor 3 in human dendritic cells. J Immunol2003; 171: 3154—3162.
11.
Nakao T., Nishiguchi M., Kikkawa S. et al. Cell surface expression of human Toll-like receptor 6 participates in the recognition of diacylated-lipopeptide and peptidoglycan: tested by mAbs. J Immunol2005; 174: 1566—1573.
12.
Seya T., Matsumoto M., Akazawa T., Toyoshima K.Differential maturation of dendritic cells by TLR adapters: application to immunotherapy. In: Toyoshima K, Barrett JC, Klein E, Hashimoto Y, Wakasugi H. (eds) Cancer Immunotherapy. Princess Takamatsu Cancer Research Fund, Princess Takamatsu Symposia 2004; 34: 12—15.
13.
Seya T., Akazawa T., Tsujita T., Matsumoto M.Role of Toll-like receptors in adjuvant-augmented vaccine therapy. eCAM2005; In press.
14.
Tapping RI, Akashi S., Miyake K., Godowski PJ, Tobias PSToll-like receptor 4, but not Toll-like receptor 2, is a signaling receptor for Escherichia and Salmonella lipopolysaccharides. J Immunol2000; 165: 5780—5787.
15.
Tsujita T., Tsukada H., Nakao M., Oshiumi H., Matsumoto M., Seya T.Sensing bacterial flagellin by membrane and soluble orthologs of Toll-like receptor 5 in rainbow trout (Onchorhynchus mikiss). J Biol Chem2004; 279: 48588—48597.
16.
Inoue N., Fukui A., Nomura M., Matsumoto M., Toyoshima K., Seya T.A novel chicken membrane-associated complement-regulatory protein: molecular cloning and functional characterization of a chicken membrane SCR protein . J Immunol2001; 166: 424—-431.
17.
Sasai M., Matsumoto M., Oshiumi H., Seya T.The TICAM-1 pathway in the Toll-like receptor signaling. J Biochem (Tokyo) 2005; In press.
18.
Funami K., Matsumoto M., Oshiumi H., Akazawa T., Yamamoto A., Seya T.Multifunctional feature of Toll-like receptor 3 cytoplasmic tail that regulates receptor localization and signaling. Int Immunol2004; 16: 1143—1154.
19.
Iwasaki A., Medzhitov R.Toll-like receptor control of the adaptive immune responses. Nat Immunol2004; 10: 987—994.
Takeda K., Takeuchi O., Akira S.Recognition of lipopeptides by Toll-like receptors. J Endotoxin Res2002; 8: 459—463.
22.
O'Neill LAAfter the Toll rush. Science2004; 303: 1481—1482.
23.
Nishiya T., DeFranco AL. Ligand-regulated chimeric receptor approach reveals distinctive subcellular localization and signaling properties of the Toll-like receptors . J Biol Chem2004; 279: 19008—19017.
24.
Akira S., Takeda K.Functions of toll-like receptors: lessons from KO mice. Compte Rendue Biol2004; 327: 581—589.
25.
Latz E., Schoenemeyer A., Visintin A. et al. TLR-9 signals after translocating from the ER to CpG DNA in the lysosome. Nat Immunol2004; 5:190-198.
26.
Schulz O., Diebold SS, Chen M. et al. Toll-like receptor 3 promotes cross-priming to virus-infected cells . Nature2005; 433: 887—892.
27.
Yoneyama M. , Kikuchi M., Natsukawa T. et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol2004; 5: 730—737.
28.
Andrejeva J. , Childs KS, Young DF et al. The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter. Proc Natl Acad Sci USA2004; 101: 17264—17269.
29.
Honda K., Ohba Y., Yanai H. et al. Spatiotemporal regulation of MyD88—IRF-7 signalling for robust type-I interferon induction. Nature2005; 434: 1035—1040.
30.
Kubo T., Hatton RD, Oliver J., Liu X., Elson CO, Weaver CTRegulatory T cell suppression and anergy are differentially regulated by proinflammatory cytokines produced by TLRactivated dendritic cells. J Immunol2004; 173: 7249—7258.
31.
Janeway Jr CA , Travers P., Walport M., Shlomchik M.Immunobiology V. New York : Garland, 2001; 35—91.
32.
Seya T., Matsumoto M., Tsuji S. et al. Two receptor theory in innate immune activation: studies on the receptors for bacillus Calmat Guillen-cell wall skeleton (BCG-CWS). Arch Immunol Ther Exp2001; 49 (Suppl. ): 13—21.
33.
Diebold SS, Kaisho T., Hemmi H., Akira S., Reis e Sousa C.Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science2004; 303: 1529—1531.
